Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Investor Growth Capital on the investment in Memira Holding AB
Mandate

Vinge advises Investor Growth Capital on the investment in Memira Holding AB

October 02, 2007

Vinge advises Investor Growth Capital in connection with the investment in Memira Holding AB, a Scandinavian laser eye surgery chain. Memira’s surgeries treat short and long sightedness as well as astigmatism, which is a common refractive error. The investment in the company will make Investor Growth Capital the owner of 40 per cent of the shares.

Investor Growth Capital is represented by partner Johan Winnerblad assisted by associates Johan Larsson, Tom Zachrisson and Theresa Kovac.

Related

Vinge is advising Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of shares whereby Xspray receives issue proceeds of approximately SEK 135 million before deduction of transaction costs.
December 03, 2024

Vinge has represented Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB

 Vinge has represented the leading infrastructure group Eleda in connection with the acquisitions of Marbit Aktiebolag, FlexiRail AB, and Hanell Entreprenad i Gävle AB from Vestum. These companies are engaged in contracting activities within the construction sector. The total purchase price for the shares amounts to 747 MSEK. All key executives in the companies will become shareholders in Eleda.
December 02, 2024

Vinge has advised Fortum in connection with the divestment of its recycling and waste business

 Vinge, alongside among others Castrén & Snellman, has advised Fortum in connection with the divestment of its recycling and waste business to Summa Equity through its portfolio company NG Group. The debt free purchase price is approximately EUR 800 million.
December 02, 2024